REQUEST A DEMO
Total
USD $0.00
Search more companies

Eli Lilly Interamerica Inc. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Eli Lilly Interamerica Inc. Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Eli Lilly Interamerica Inc. is a company based in Ecuador, with its head office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on March 15, 2001. 16 (2016) employees currently work for Eli Lilly Interamerica Inc.. From the latest financial highlights, Eli Lilly Interamerica Inc. reported a net sales revenue drop of 88.21% in 2022. Its’ total assets recorded a negative growth of 13.72%.

Headquarters
Calle 10 de Agosto 10640, Quifatex Bldg. , Floor 3
Quito; Pichincha;

Contact Details: Purchase the Eli Lilly Interamerica Inc. report to view the information.

Basic Information
Total Employees:
Purchase the Eli Lilly Interamerica Inc. report to view the information.
Outstanding Shares:
Purchase the Eli Lilly Interamerica Inc. report to view the information.
Registered Capital:
Purchase the Eli Lilly Interamerica Inc. report to view the information.
Incorporation Date:
March 15, 2001
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Eli Lilly Interamerica Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-88.21%
Total operating revenue
-85.1%
Operating profit (EBIT)
-98.9%
EBITDA
-95.84%
Net Profit (Loss) for the Period
N/A
Total assets
-13.72%
Total equity
-4.74%
Operating Profit Margin (ROS)
-5.38%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-0.26%
Quick Ratio
2.6%
Cash Ratio
5.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?